Colorado legislators push obesity prevention bill, governor’s approval is uncertain

Erin Harrop of Mental Health Colorado echoed Chastain’s concerns with the pharmaceutical industry profiting from weight loss medications whose long-term effects have not yet been fully studied. She said the longest trial of GLP-1 medications on obese individuals lasted only two years.

“Like the opioid epidemic, the pharmaceutical industry stands to make huge profits before the long-term studies are even completed as desperate patients and well-meaning providers seek solutions,” she said.